Clavamox Powder for Suspension

About Clavamox 125 mg + 31.25 mg/5 ml Powder For Suspension

Clavamox is a broad-spectrum penicillin antibiotic combining amoxicillin with clavulanic acid. It is supplied as a powder for suspension with a strength of 125 mg + 31.25 mg/5 ml and is used for certain bacterial infections.

There are 105 brands of Amoxicillin + Clavulanic Acid listed in Bangladesh. The lowest listed price is Moxilin CV 125 mg + 31.25 mg/5 ml Powder For Suspension at ৳ 1 per unit.

What is Clavamox 125 mg + 31.25 mg/5 ml Powder For Suspension?

Clavamox is an antibacterial medicine that pairs amoxicillin, a penicillin antibiotic, with clavulanic acid. The combination is designed to help overcome certain bacteria that would otherwise break down amoxicillin. It is available as a powder for suspension with a strength of 125 mg + 31.25 mg/5 ml. Doctors prescribe it for short-term treatment of some bacterial infections of the upper and lower respiratory tract, and of the genito-urinary tract. Because it is an antibiotic, it should only be used when a doctor has confirmed that it is appropriate.

Uses of Clavamox

Clavamox is used for short-term treatment of certain bacterial infections. These include infections of the upper respiratory tract, such as tonsillitis, sinusitis and middle-ear infection; infections of the lower respiratory tract, such as acute and chronic bronchitis and pneumonia; and genito-urinary infections such as cystitis and urethritis. It is not for viral illnesses. Your doctor will decide whether it is suitable for the infection being treated.

How to use Clavamox

Use Clavamox exactly as the doctor prescribes. The doctor decides the dose and the length of the course, including for children. The powder must be reconstituted before use; follow the pharmacist's instructions for mixing and measuring. Shake the bottle well before each use and measure with the proper spoon or syringe. Taking it at the start of meals may reduce stomach upset. Store as directed and do not keep a reconstituted bottle longer than the pharmacist advises.

Side effects of Clavamox

Side effects are uncommon and are usually mild and short-lived. Diarrhoea, indigestion, nausea, vomiting and candidiasis have been reported. Taking the medicine at the start of a meal may reduce stomach upset. Skin rashes sometimes occur. Rarely, hepatitis and cholestatic jaundice, and serious skin reactions such as erythema multiforme, Stevens-Johnson syndrome and exfoliative dermatitis, have been reported. As with other beta-lactam antibiotics, angioedema and anaphylaxis have been reported. Seek urgent medical help for a severe allergic reaction.

Safety and precautions

Do not take Clavamox if you have had an allergic reaction to penicillin, or if you have had cholestatic jaundice linked to Clavamox or penicillin. Cross-sensitivity with other beta-lactam antibiotics such as cephalosporins is possible, so tell the doctor about any antibiotic allergy. Use with care if you are on anticoagulation therapy or have severe liver problems, and the dose may need adjusting in kidney impairment. Animal studies showed no teratogenic effect, but use in pregnancy is not recommended unless the doctor considers it essential; small amounts of amoxicillin can pass into breast milk. Ask the doctor before use in pregnancy or breastfeeding.

Frequently asked questions

What is Clavamox used for and what kind of medicine is it?

Clavamox is a broad-spectrum penicillin antibiotic. It contains amoxicillin with clavulanic acid and is used for short-term treatment of certain bacterial infections of the upper and lower respiratory tract and the genito-urinary tract. It does not treat viral infections.

Who should avoid Clavamox or ask the doctor first?

People with a history of penicillin allergy, or previous Clavamox or penicillin-associated cholestatic jaundice, should not take it. Tell the doctor about any antibiotic allergy, liver or kidney problems, or anticoagulant therapy before starting. The doctor will decide whether it is suitable.

Is Clavamox safe in pregnancy or breastfeeding?

Animal studies showed no teratogenic effect, but use in pregnancy is not recommended unless the doctor considers it essential. Small amounts of amoxicillin can be detected in breast milk. Ask the doctor before using Clavamox during pregnancy or breastfeeding.

Can Clavamox interact with other medicines?

Clavamox may reduce the effectiveness of oral contraceptives, so patients should be warned. Taking allopurinol with amoxicillin can increase the chance of allergic skin reactions. Prolongation of bleeding time and prothrombin time has been reported in some patients. Tell the doctor or pharmacist about all medicines you take.

Indications

Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • ... Read more
Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • Genito-urinary tract infections e.g.cystitis,urethritis,pyelonephritis.
  • Skin and soft tissue infections.
  • Bone and joint infections e.g.osteomyelitis.
  • Other infections e.g.septic abortion,puerperal sepsis,intra-abdominal sepsis etc.

Pharmacology

Pharmacodynamic properties: Co-amoxiclav is an antibacterial combination consisting of the antibiotic Amoxicillin and the (3-lactamase inhibitor Clavulanic Acid. Amoxicillin has a broad spectrum of bactericidal activity against many Gram-positive & Gram-negative microorganisms but it is susceptible to degradation by (3-lactamases and therefore the spectrum of activity does not include microorganisms, which produce these enzymes. Clavulanic acid possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in microorganisms resistant to penicillins and cephalosporins. Thus Clavulanic acid in this preparation protects Amoxicillin from degradation by (3-lactamase enzymes and effectively extends the antibiotic spectrum to embrace a wide range of microorganisms.

Pharmacokinetic properties: The pharmacokinetics of the two components of Co-amoxiclav is closely matched. Peak serum levels of both occur about one hour after oral administration. Absorption of Co-amoxiclav is optimized at the start of a meal. Both clavulanate and Amoxicillin have low levels of serum binding; about 70% remains free in the serum. Doubling the dosage of Co-amoxiclav approximately doubles the serum levels achieved.

Dosage & Administration

Adults and children over 12 years:

Tablet:
  • The usual adult dose is one 625 mg Tablet every 12 hours or one 375 mg Tablet every 8 hours.
  • For more severe infections and infections of the respiratory tract, the dose should be one 1 gm Tablet every 12 hours or one 625 mg Tablet every 8 hours.
Suspension:
  • Children 6-12 years: 2 teaspoonful every 8 hours.
  • Children 1-6years: 1 teaspoonful every 8 hours.
  • Children below 1 year: 25 mg/kg/day in divided doses every 8 hours, for example a 7.5 kg child would require 2 ml suspension t.i.d, Treatment should not be extended beyond 14 days without review.
Forte suspension:
  • The usual recommended daily dosage: 25/3.6 mg/kg/day in mild to moderate infections (upper respiratory tract infections e.g. recurrent tonsilitis, lower respiratory infections, and skin and soft tissue infections)।
  • For serious infections: 45/6.4 mg/kg/day for the treatment of more serious infections (upper respiratory tract infections, e.g. otitis media and sinusitis, lower respiratory infections e.g. bronchopneumonia, and urinary tract infections).
Children of 2 to 12 years:
Mild to moderate infections:
  • 25/3.6 mg/kg/day (Suspension)
  • 2-6 years (13-21 kg) 2.5 ml suspension b.i.d
  • 7-12years (22-40kg) 5 ml suspension b.i.d
Serious infections:
  • 45/6.4 mg/kg/day (Forte Suspension)
  • 2-6 years (13-21 kg) 5 ml suspension b.i.d
  • 7-12 years (22-40 kg) 10 ml suspension b.i.d
IV Injection

Adults-
  • Usually, 1.2 gm every 8 hours
  • Increased in more serious infections to 1.2 gm every 6 hours
  • For surgical prophylaxis: The usual dose is 1.2 gm at induction, for high risk procedures (eg. colorectal surgery) up to 2-3 gm may be given every 8 hours.
Children-
  • 0 to 3 months: 30 mg/kg every 8 hours. (every 12 hours in the perinatal period and in premature infants.
  • 3 months to 12 years: Usually 30 mg/kg every 8 hours increased in more serious infection to 30 mg/kg every 6 hours.

Interaction

Prolongation of bleeding time and prothrombin time have been reported in some patients receiving Co-amoxiclav. In common with other broad-spectrum antibiotics, Co-amoxiclav may reduce the efficacy of oral contraceptives and patients should be warned accordingly. Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of Co-amoxiclav and allopurinol.

Contraindications

History of Penicillin hypersensitivity. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins. Also contraindicated for patients with a previous history of Co-amoxiclav or Penicillin-associated cholestatic jaundice.

Side Effects

Side effects, as with Amoxicillin, are uncommon and mainly of a mild and transitory nature. Diarrhoea, pseudomembranous colitis, indigestion, nausea, vomiting and candidiasis have been reported, if gastrointestinal side effects occur with oral therapy, that may be reduced by taking Co-amoxiclav at the start of meals. Hepatitis and cholestatic jaundice have been reported rarely but are usually reversible. Urticarial and erythematous rashes sometimes occur. Rarely erythema multiforme, Stevens-Johnson Syndrome and exfoliative dermatitis have been reported. In common with other beta-lactam antibiotics, angioedema and anaphylaxis have been reported.

Pregnancy & Lactation

Animal studies with orally and parenterally administered Co-amoxiclav have shown no teratogenic effect. The drug has been used orally in human pregnancy in a limited number of cases with no untoward effect; however, the use of Co-amoxiclav in pregnancy is not recommended unless considered essential by the physician. During lactation, trace quantities of Amoxicillin can be detected in breast milk.

Precautions & Warnings

Co-amoxiclav should be used with care in patients on anticoagulation therapy or with severe hepatic dysfunction. In patients with moderate or severe renal impairment, dosage should be adjusted. During the administration of a high dose of Co-amoxiclav adequate fluid intake and urinary output should be maintained to minimize the possibility of crystalluria.

Overdose Effects

Problems of overdose with Co-amoxiclav are unlikely to occur, if encountered gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Co-amoxiclav may be removed from the circulation by haemodialysis.

Storage Conditions

This should be stored below 25°C, protected from light and moisture. Once reconstituted suspension should be kept in the refrigerator (but not frozen) and should be usedby 7 days. Once reconstituted vial must be used within 20 minutes.

Alternative brands of Amoxicillin + Clavulanic Acid

Other brands with the same generic name, cheapest first.

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.